TEPYLUTE
Live / Registered — Registered (as of 21 Jan 2025)
What this means for you
Registered since 21 Jan 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98211536
- Registration number
- 7658017
- Mark type
- Design + words
- Filed
- 05 Oct 2023
- Published for opposition
- 03 Dec 2024
- Registered
- 21 Jan 2025
- Attorney of record
- Sean P. McMahon
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and medicinal preparations and substances for the treatment of metabolic diseases and disorders, oncological diseases and disorders, dermatological diseases and disorders, hormonal diseases and disorders, viral diseases and disorders, bacterial diseases and disorders, infectious diseases and disorders, viral diseases and disorder, as well as diseases and disorders of the alimentary tract, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system, and respiratory system; pharmaceutical and medicinal preparations and substances for use in oncology; pharmaceutical preparations, products and substances for human use for the treatment of metabolic diseases and disorders, oncological diseases and disorders, dermatological diseases and disorders, hormonal diseases and disorders, viral diseases and disorders, bacterial diseases and disorders, infectious diseases and disorders, viral diseases and disorder, as well as diseases and disorders of the alimentary tract, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system, and respiratory system; pharmaceutical preparations and substances for the prevention and treatment of cancer; pharmaceutical compounds for treating cancer; biological preparations for the treatment of cancer; pharmaceutical preparations and substances for the prevention of tumours; anti-cancer drugs and pharmaceutical preparations
- Class 042 — Scientific and technological services: Research and development services in the field of metabolic diseases and disorders, oncological diseases and disorders, dermatological diseases and disorders, hormonal diseases and disorders, viral diseases and disorders, bacterial diseases and disorders, infectious diseases and disorders, viral diseases and disorder, as well as diseases and disorders of the alimentary tract, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system, and respiratory system; biological research; scientific research services; research and development services in the pharmaceutical and biotechnology fields; research services relating to the development and testing of pharmaceutical preparations and medicines; pharmaceutical drug development services; pharmaceutical product evaluation; testing and inspection of pharmaceutical preparations and medicines; product safety and quality testing in the pharmaceutical and biotechnology fields; provision of information and data relating to research and development in the pharmaceutical and biotechnology fields
Owner
- Shorla Pharma Limited, Clonmel, Co. Tipperary, IE
- Shorla Pharma Limited, Clonmel, Co. Tipperary, IE
- Shorla Pharma Limited, Clonmel, Co. Tipperary, IE
Prosecution history
- 21 Jan 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 21 Jan 2025 — REGISTERED-PRINCIPAL REGISTER
- 03 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Dec 2024 — PUBLISHED FOR OPPOSITION
- 27 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Nov 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 04 Nov 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 04 Nov 2024 — ASSIGNED TO LIE
- 08 Aug 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 12 May 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 May 2024 — NON-FINAL ACTION E-MAILED
- 12 May 2024 — NON-FINAL ACTION WRITTEN
- 10 May 2024 — ASSIGNED TO EXAMINER
- 25 Apr 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED